Paper35995378
Protective activities of ellagic acid and urolithins against kidney toxicity of environmental pollutants: A review.
García-Niño WR and 4 others. Environ Toxicol Pharmacol, 2022. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Protective activities of ellagic acid and urolithins against kidney toxicity of environmental pollutants: A review. Papers, record 35995378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35995378
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protective activities of ellagic acid and urolithins against kidney toxicity of environmental pollutants: A review.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Air Pollutants | Major topic |
| Environmental Pollutants | Major topic |
| Kidney Diseases | Major topic |
| Mycotoxins | Major topic |
| Pesticides | Major topic |
| Renal Insufficiency | Major topic |
| Anti-Inflammatory Agents | |
| Antioxidants | |
| Ellagic Acid | |
| Humans | |
| Kidney | |
| Oxidative Stress |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42351813 | Ellagic Acid Attenuates Gentamicin Nephrotoxicity by Integrated Modulation of ER Stress-Associated Apoptosis-Autophagy Crosstalk and Attenuation of Nrf2/HO-1 Signaling. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351813 | PubMed |
| 42294271 | Synergistic anticancer effect of ellagic acid and Kaempferol combination in a mouse model of breast cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42294271 | PubMed |
| 42228637 | Lifestyle and Environment Aspects Challenging Kidney Health. | Kidney Blood Press Res | 2026 | https://conductscience.org/library/papers/42228637 | PubMed |
| 40825827 | Liposomal ellagic acid enhances the regenerative potential of ADMSC-laden nanofibrous PCL scaffolds in a rat model of spinal cord injury. | Sci Rep | 2025 | https://conductscience.org/library/papers/40825827 | PubMed |
| 40180655 | Urolithin as a Metabolite of Ellagitannins and Ellagic Acid from Fruits and Nuts Produced by the Gut Microbiota: Its Role on Non-Communicable Diseases. | Curr Nutr Rep | 2025 | https://conductscience.org/library/papers/40180655 | PubMed |
| 38611284 | Phytochemicals Involved in Mitigating Silent Toxicity Induced by Heavy Metals. | Foods | 2024 | https://conductscience.org/library/papers/38611284 | PubMed |
| 38005368 | The Green Synthesis of Reduced Graphene Oxide Using Ellagic Acid: Improving the Contrast-Enhancing Effect of Microbubbles in Ultrasound. | Molecules | 2023 | https://conductscience.org/library/papers/38005368 | PubMed |
| 38002335 | Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence. | Biomolecules | 2023 | https://conductscience.org/library/papers/38002335 | PubMed |
| 37125148 | Pretreatment of ellagic acid protects ifosfamide-induced acute nephrotoxicity in rat kidneys: A mitochondrial, histopathological and oxidative stress approaches. | Toxicol Rep | 2023 | https://conductscience.org/library/papers/37125148 | PubMed |
| 36838811 | In Vitro Gastrointestinal Digestion Affects the Bioaccessibility of Bioactive Compounds in Hibiscus sabdariffa Beverages. | Molecules | 2023 | https://conductscience.org/library/papers/36838811 | PubMed |
| 36358490 | Targeted UHPLC-MS Analysis Reveals Disparate Polyphenol Composition and Concentration in Muscadine Grape Supplements with Proportional Antioxidant Activity. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36358490 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35995378
GET https://conductscience.org/api/papers/v1/35995378/authors